Related Experiment Videos
Monocyte cytotoxicity in connective tissue diseases. Correlation with disease groups
Scandinavian Journal of Rheumatology
|January 1, 1981
Summary
Rheumatoid arthritis patients showed increased antibody-dependent cytotoxic plaque-forming cells (PFCs). Seropositive RA patients had higher PFC levels than seronegative patients, while juvenile RA patients had lower levels compared to controls.
Area of Science:
- Immunology
- Rheumatology
- Cellular Biology
Background:
- Antibody-dependent cellular cytotoxicity (ADCC) plays a role in autoimmune diseases.
- Monocyte-derived cells are involved in immune responses and inflammation.
- Assessing specific immune cell populations can provide insights into disease pathogenesis.
Purpose of the Study:
- To quantify the proportion of antibody-dependent cytotoxic plaque-forming cells (PFCs) with monocyte characteristics.
- To compare these PFC levels in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), juvenile rheumatoid arthritis (JRA), and systemic lupus erythematosus (SLE) against healthy controls.
- To investigate potential differences between seropositive and seronegative RA patients.
Main Methods:
- Peripheral blood mononuclear leukocyte suspensions were analyzed.
- The proportion of antibody-dependent cytotoxic plaque-forming cells (PFCs) with monocyte features was estimated.
- Patient groups included RA (seropositive and seronegative), AS, JRA, and SLE.
Main Results:
- Patients with RA and AS exhibited higher mean proportions of PFCs compared to healthy adult blood donors.
- Seropositive RA patients demonstrated a significantly higher proportion of PFCs than seronegative RA patients.
- SLE patients had PFC levels comparable to controls, while JRA patients showed a lower percentage of these cells than age-matched healthy children.
Conclusions:
- Elevated antibody-dependent cytotoxic plaque-forming cells (PFCs) with monocyte characteristics are associated with rheumatoid arthritis and ankylosing spondylitis.
- Serostatus in RA correlates with the proportion of these specific immune cells.
- Juvenile rheumatoid arthritis may involve distinct immunoregulatory mechanisms affecting these PFCs.